Labeled compounds that bind to a thrombopoietin receptor
US6506362B1 · kind B1 · utility
18Cited by
11References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 10, 2001 |
| Grant date | Jan 14, 2003 |
| Priority date | — |
| Expiry date | Jun 14, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/524
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Described are peptides and peptide mimetics that bind to and activate the thrombopoietin receptor. Such peptides and peptide mimetics are useful in methods for treating hematological disorders and particularly, thrombocytopenia resulting from chemotherapy, radiation therapy, or bone marrow transfusions as well as in diagnostic methods employing labeled peptides and peptide mimetics.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.